Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)
CNY 37.71
(-1.33%)
CNY 37.71
(-1.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 92.86 Million | 103.95 Million | 88.25 Million | 62.99 Million | 56.97 Million | 44.1 Million |
| Net Income | 182.89 Million | 158.04 Million | 108.79 Million | 74.16 Million | 47.93 Million | 20.16 Million |
| Depreciation & Amortization | 44.92 Million | 39.97 Million | 28.47 Million | 10.45 Million | 7.78 Million | 5.32 Million |
| Deferred income taxes | -22.13 Million | -11.04 Million | -2.37 Million | -325.15 Thousand | 356.1 Thousand | -635.2 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -225.73 Million | -131.61 Million | -65.22 Million | -29.35 Million | -368.67 Thousand | 11.13 Million |
| Other non-cash items | 31.18 Million | 37.55 Million | 16.21 Million | 7.73 Million | 1.62 Million | 7.48 Million |
| Investing Cash Flow | -88.66 Million | -11.5 Million | -275.78 Million | -35.7 Million | -15.15 Million | 20.27 Million |
| Investments in PPE | -72.95 Million | -103.86 Million | -84.95 Million | -27.03 Million | -25.67 Million | -16.41 Million |
| Acquisitions | -22.55 Million | 1.75 Million | 84.95 Million | -3.99 Million | - | 9.93 Million |
| Investment purchases | -20 Million | -85.75 Million | -495 Million | -79.09 Million | -20 Million | - |
| Sales/Maturities of investments | 4.29 Million | 178.11 Million | 304.17 Million | 74.41 Million | 20.36 Million | 1.07 Million |
| Other Investing Activities | -15.7 Million | -1.74 Million | -84.95 Million | 0.83 | 10.14 Million | 35.61 Million |
| Financing Cash Flow | 77.8 Million | 26.21 Million | 568.47 Million | 5.52 Million | 2.97 Million | -38.3 Million |
| Debt repayment | -181.95 Million | -153 Million | -33.5 Million | -25.5 Million | -12 Million | -20 Million |
| Dividends payments | -48 Million | -21.2 Million | -1.24 Million | -1.07 Million | -306.24 Thousand | -1.05 Million |
| Common Stock Repurchased | - | - | 16.89 Million | - | - | - |
| Common Stock Issuance | - | - | -16.89 Million | - | - | - |
| Other Financing Activities | -48.63 Million | 206.2 Million | 603.22 Million | 32.09 Million | 15.27 Million | -17.24 Million |
| Accounts receivables | -250.51 Million | -151.92 Million | -143.03 Million | -35.12 Million | -30.01 Million | -35.34 Million |
| Accounts payables | 48.77 Million | 36.04 Million | 81.74 Million | 8.64 Million | 29.13 Million | 49.52 Million |
| Inventory | -1.87 Million | -4.69 Million | -1.55 Million | -2.54 Million | 152.26 Thousand | -2.4 Million |
| Other working capital | 26.64 Million | -11.04 Million | -2.37 Million | -325.15 Thousand | 356.06 Thousand | 13.53 Million |
| Cash at beginning of period | 608.92 Million | 490.25 Million | 109.3 Million | 76.48 Million | 31.7 Million | 5.62 Million |
| Cash at end of period | 690.93 Million | 608.92 Million | 490.25 Million | 109.3 Million | 76.48 Million | 31.7 Million |
| Capital Expenditure | -72.95 Million | -103.86 Million | -84.95 Million | -27.03 Million | -25.67 Million | -16.41 Million |
| Effect of forex changes on cash | - | -0.63 | - | -0.33 | -0.09 | 1.00 |
| Net cash flow / Change in cash | 82 Million | 118.67 Million | 380.94 Million | 32.81 Million | 44.78 Million | 26.08 Million |
| Free Cash Flow | 19.9 Million | 91.91 Thousand | 3.29 Million | 35.96 Million | 31.3 Million | 27.69 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 59.11 Million | 75.81 Million | 72.75 Million | 182.89 Million | 13.68 Million | 53.08 Million |
| Depreciation & Amortization | - | 16.69 Million | 16.69 Million | 44.92 Million | 44.92 Million | -21.38 Million |
| Deferred income taxes | 16.23 Million | - | - | -22.13 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -267.04 Million | - | -225.73 Million | -252.38 Million | 167.5 Million |
| Other non-cash items | 97.51 Million | -129.98 Million | -66.55 Million | 31.18 Million | 259.8 Million | -130.39 Million |
| Investing Cash Flow | -34.96 Million | -9.17 Million | -123.66 Million | -88.66 Million | -2.27 Million | -22.12 Million |
| Investments in PPE | -792.09 Thousand | -19.16 Million | -18.83 Million | -72.95 Million | -8.56 Million | -22.72 Million |
| Acquisitions | 6.83 Million | -11.93 Thousand | -96 Million | -22.55 Million | -30.29 Million | 7.65 Million |
| Investment purchases | -61 Million | -20 Million | -9 Million | -20 Million | 6 Million | -7.65 Million |
| Sales/Maturities of investments | 20 Million | 30 Million | 159.25 Thousand | 4.29 Million | 810.82 Thousand | 159.25 Thousand |
| Other Investing Activities | - | -11.93 Thousand | -8.82 Million | -15.7 Million | 6.29 Million | 435.82 Thousand |
| Financing Cash Flow | -8.09 Million | -124.71 Million | 145.7 Million | 77.8 Million | 27.91 Million | 16.37 Million |
| Debt repayment | -20.82 Million | -114.52 Million | -151.77 Million | -181.95 Million | -67.24 Million | -50.27 Million |
| Dividends payments | - | -4.01 Million | -3.59 Million | -48 Million | -864.95 Thousand | -2.54 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -28.91 Million | -1.53 Million | -2.47 Million | -48.63 Million | -38.46 Million | 69.19 Million |
| Accounts receivables | - | -267.05 Million | - | -250.51 Million | -250.51 Million | 166.73 Million |
| Accounts payables | - | - | - | 48.77 Million | - | - |
| Inventory | - | 8365.00 | - | -1.87 Million | -1.87 Million | 764.41 Thousand |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 514.42 Million | 719.17 Million | 690.93 Million | 608.92 Million | 599.25 Million | 536.36 Million |
| Cash at end of period | 644.23 Million | 514.42 Million | 719.17 Million | 690.93 Million | 690.93 Million | 599.25 Million |
| Capital Expenditure | -792.09 Thousand | -19.16 Million | -18.83 Million | -72.95 Million | -8.56 Million | -22.72 Million |
| Effect of forex changes on cash | - | - | - | - | - | -159.24 Thousand |
| Net cash flow / Change in cash | 129.8 Million | -204.75 Million | 28.24 Million | 82 Million | 91.67 Million | 62.89 Million |
| Free Cash Flow | 172.07 Million | -90.02 Million | -12.63 Million | 19.9 Million | 57.45 Million | 46.08 Million |
RDEMF
CUBI
300953
MGLLF
8338
NTPIF